Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes
about
Nuclear receptors in bone physiology and diseasesPPARalpha: energy combustion, hypolipidemia, inflammation and cancerActivation of PPARs α, β/δ, and γ Impairs TGF-β1-Induced Collagens' Production and Modulates the TIMP-1/MMPs Balance in Three-Dimensional Cultured Chondrocytes.PPAR-γ regulates carnitine homeostasis and mitochondrial function in a lamb model of increased pulmonary blood flowBone morphogenetic protein-7 promotes chondrogenesis in human amniotic epithelial cells.Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes.Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.Fibrates as therapy for osteoarthritis and rheumatoid arthritis? A systematic review.Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.PPARgamma2 expression in growth plate chondrocytes is regulated by p38 and GSK-3.PPAR modulation of kinase-linked receptor signaling in physiology and disease.Arjunolic Acid, a Peroxisome Proliferator-Activated Receptor Alpha Agonist Regresses Cardiac Fibrosis by Inhibiting Non-canonical TGF-β Signaling.Drug-Mediated Regulation of Glycosaminoglycan Biosynthesis.Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
P2860
Q26853017-61F2008B-8E3D-471F-BF6A-1197D143F141Q33805104-1EF24E8E-EA0D-4714-93B3-BD663F4A79EDQ34210856-F5C1C215-50B9-47DB-A6E1-2DAA45E47983Q34409704-B3FF1313-4CB6-4D0D-BC0D-3982205732C8Q35013184-B23F3ADA-DAA2-48DB-9D5A-7C8E07BDD924Q36465483-2686F8A3-D6B2-4002-B65C-06846C381A4BQ36618918-C4B2F37F-3DF9-4D3D-AD4B-B69F0F9EBE86Q36638653-7DC54EB5-3A54-4557-9DB8-EFC98856096FQ36641580-A0019424-5688-49DC-AC27-D574216B7282Q37334975-88D01EB8-37EA-458F-A81B-00A8F199FD93Q37765370-8BD5F839-303B-49E4-8CFF-67989942A774Q38618013-7DB24FE7-DB5F-4AE5-90FB-ED9EA749FEB8Q39060517-1B2DCC42-AAB8-4CAA-9E11-5F7CE6EA2F76Q42109507-1C04CA8A-E15E-45C6-9CFF-92B18998DD3BQ46830543-A037E960-D018-49A4-822D-B268306E549A
P2860
Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans' production in chondrocytes
description
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Mai 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/05/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/05/01)
@nl
наукова стаття, опублікована в травні 2007
@uk
مقالة علمية (نشرت في مايو 2007)
@ar
name
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@ast
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@en
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@nl
type
label
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@ast
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@en
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@nl
prefLabel
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@ast
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@en
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@nl
P2093
P1476
Agonists of peroxisome prolife ...... ns' production in chondrocytes
@en
P2093
A. Bianchi
B. Terlain
J. Y. Jouzeau
M. Koufany
P. E. Poleni
S. Etienne
S. Sebillaud
P304
P356
10.1016/J.JOCA.2006.10.009
P577
2007-05-01T00:00:00Z